**Question:** Amongst the renal cystic diseases, the one that is autosomal recessive is:

A. Polycystic Kidney Disease (PKD)
B. Polycystic Liver Disease (PLD)
C. Autosomal Dominant Polycystic Kidney Disease (ADPKD)
D. Autosomal Recessive Polycystic Kidney Disease (ARPKD)

**Core Concept:**
Autosomal Recessive Polycystic Kidney Disease (ARPKD) is a rare genetic disorder characterized by the formation of multiple cysts in the liver and kidneys. It belongs to the group of autosomal recessive diseases, meaning that the genetic trait is inherited from both parents, and the child expresses the disease if they inherit the abnormal gene from both parents.

**Why the Correct Answer is Right:**
ARPKD is caused by mutations in the PKHD1 gene, which is responsible for the production of fibrocystin protein. The absence or dysfunction of this protein leads to the formation of cysts in the kidneys and liver. ARPKD is an autosomal recessive disorder, which implies that the affected individual has to inherit the abnormal gene from both parents for the disease to manifest.

**Why Each Wrong Option is Incorrect:**

A. Polycystic Kidney Disease (PKD) is not autosomal recessive, but rather autosomal dominant (ADPKD). PKD is caused by mutations in the PKD1 or PKD2 genes, which result in the formation of fluid-filled cysts in the kidneys.

B. Polycystic Liver Disease (PLD) is not a distinct entity; it is a part of PKD1 or PKD2 mutations, which cause the formation of cysts in the liver, kidneys, and pancreas.

C. Autosomal Dominant Polycystic Kidney Disease (ADPKD) is another type of cystic kidney disease, caused by mutations in the PKD1 or PKD2 genes. It is different from ARPKD due to its autosomal dominant inheritance pattern.

D. Autosomal Recessive Polycystic Kidney Disease (ARPKD) is the correct answer, as it is caused by mutations in the PKHD1 gene and follows an autosomal recessive pattern of inheritance.

**Clinical Pearl:**
ARPKD is a rare disease with an incidence of approximately 1 in 20,000 births. The disease usually presents in infancy or early childhood with symptoms such as abdominal distension, obstructive jaundice, and pulmonary hypoplasia. Treatment options are limited, and supportive care is the mainstay of management. Early diagnosis and treatment can improve survival rates and quality of life for affected individuals and their families.

**Why Each Wrong Option is Incorrect:**

A. Autosomal Dominant Polycystic Kidney Disease (ADPKD) is caused by mutations in the PKD1 or PKD2 genes and is different from ARPKD due to its autosomal dominant inheritance pattern.

B. Polycystic Liver Disease (PLD) is a part of PKD1 or PKD2 mutations and is not a distinct entity.

C. Autosomal Re